Scaled Net Operating Assets (SNOA) is calculated as the difference between operating assets and operating liabilities, scaled by lagged total assets.
Biogena Group Invest AG's operating assets for the quarter that ended in Jan. 2026 was €8.84 Mil. Biogena Group Invest AG's operating liabilities for the quarter that ended in Jan. 2026 was €0.06 Mil. Biogena Group Invest AG's Total Assets for the quarter that ended in Jan. 2025 was €8.94 Mil. Therefore, Biogena Group Invest AG's scaled net operating assets (SNOA) for the quarter that ended in Jan. 2026 was 0.98.
Biogena Group Invest AG Scaled Net Operating Assets Related Terms
Biogena Group Invest AG Scaled Net Operating Assets Historical Data
* Premium members only.
The historical data trend for Biogena Group Invest AG's Scaled Net Operating Assets can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Biogena Group Invest AG Scaled Net Operating Assets Chart
WBO:BIO vs KHC, GIS, HRL: Scaled Net Operating Assets Comparison
For the Packaged Foods subindustry, Biogena Group Invest AG's Scaled Net Operating Assets, along with its competitors' market caps and Scaled Net Operating Assets data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Biogena Group Invest AG Scaled Net Operating Assets vs Consumer Packaged Goods Industry
For the Consumer Packaged Goods industry and Consumer Defensive sector, Biogena Group Invest AG's Scaled Net Operating Assets distribution charts can be found below:
* The bar in red indicates where Biogena Group Invest AG's Scaled Net Operating Assets falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
What does a Scaled Net Operating Assets of 0.98 mean?
Biogena Group Invest AG (WBO:BIO) has a Scaled Net Operating Assets of 0.98 as of Jan. 2026. Scaled net operating assets equals current-period operating assets less operating liabilities less prior-period total assets. View historical data on Biogena Group Invest AG and its competitors.
Is Biogena Group Invest AG's Scaled Net Operating Assets too high?
Biogena Group Invest AG's current Scaled Net Operating Assets is 0.98. Overall, Biogena Group Invest AG has a GF Score™ of 65/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Biogena Group Invest AG's Scaled Net Operating Assets compare to KHC and GIS?
Biogena Group Invest AG's Scaled Net Operating Assets of 0.98 can be compared against companies in the Consumer Packaged Goods industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Scaled Net Operating Assets for a Consumer Packaged Goods company?
A good Scaled Net Operating Assets depends on the Consumer Packaged Goods industry context. However, Scaled Net Operating Assets should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Scaled Net Operating Assets mean?
A high Scaled Net Operating Assets can signal that a stock is expensive relative to its fundamentals. Scaled net operating assets equals current-period operating assets less operating liabilities less prior-period total assets. View historical data on Biogena Group Invest AG and its competitors. Biogena Group Invest AG's current Scaled Net Operating Assets is 0.98. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Biogena Group Invest AG stock overvalued right now?
Based on GuruFocus' analysis, Biogena Group Invest AG (WBO:BIO) is currently considered Modestly Overvalued. The stock's GF Value™ is €3.47, compared to a current price of €4.44 — trading 28% above its estimated fair value. The current Scaled Net Operating Assets is 0.98. Biogena Group Invest AG's overall GF Score™ is 65/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Scaled Net Operating Assets calculated?
Scaled Net Operating Assets is calculated from a company's financial statements. For Biogena Group Invest AG (WBO:BIO), the current Scaled Net Operating Assets is 0.98 as of Jan. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Biogena Group Invest AG (WBO:BIO) Overvalued in 2026?
Based on GuruFocus' analysis, Biogena Group Invest AG stock appears to be overvalued.
The current stock price of €4.44 is trading 28% above its estimated GF Value™ of €3.47.
GuruFocus considers Biogena Group Invest AG to be Modestly Overvalued.
Key valuation signals for WBO:BIO:
Scaled Net Operating Assets: 0.98
GF Value™: €3.47 vs. price of €4.44 (28% above fair value)
No single metric tells the full story. See the WBO:BIO stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Biogena Group Invest AG is a holding company. It is engaged in the development and distribution of products and services in the field of health and nutrition. In particular, the focus is on iron, mineral and osteoporosis product innovations and new integrated solutions in the area of workplace health promotion. Its products include vitamin, mineral, enzymes, medicinal mushrooms, among others.
65GF Score
Get the complete analysis for WBO:BIO
Scaled Net Operating Assets is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
WBO:BIO has been successfully added to your 